Bambusa Therapeutics is a biotechnology company developing transformative treatments for inflammatory and immunological conditions.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Clear Labs develops next-generation sequencing platforms that integrate DNA sequencing, robotics, and cloud-based bioinformatics for diagnostics.

Saluda Medical develops and commercializes the Evoke® System, a closed-loop spinal cord stimulation device for managing chronic pain.

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.